MedTrace Logo

Renal Anemia Refractory to Erythropoietin

NCT03480178 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2019-01-02

No results posted yet for this study

Summary

This study evaluates the renal anemia refractory to Epo . in hemodialysis patients. all of participants will receive Epo. and identify various factors contributing to etiology of renal anemia in Epo- resistant patients.

Conditions

  • ESRD
  • Renal Anemia

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-31
Primary Completion
2019-01-31
Completion
2019-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03480178 on ClinicalTrials.gov